CRMD 8-K: Acquisition
CorMedix
Filed with the SEC on · accession 0001213900-26-120016
CRMD filed a 8-K (current report) with the SEC on Nov 16, 2026. CorMedix disclosed that it is pursuing a proposed acquisition involving Heron Therapeutics, with Heron expected to file a proxy statement and CorMedix to issue shares to Heron in a private placement. The stock moved +3.4% by the first close after the filing.
Summary of the filing
CorMedix disclosed that it is pursuing a proposed acquisition involving Heron Therapeutics, with Heron expected to file a proxy statement and CorMedix to issue shares to Heron in a private placement. The filing also furnished an investor call transcript regarding Q3 2026 financial results.
Key details
How CRMD stock reacted
Close before
$4.66
Nov 13, 2026
First close after
+3.43%
$4.82
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CRMD, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CRMD?
Click hereFrequently asked questions
What did CRMD file with the SEC on Nov 16, 2026?
CRMD filed a 8-K (Acquisition). CorMedix disclosed that it is pursuing a proposed acquisition involving Heron Therapeutics, with Heron expected to file a proxy statement and CorMedix to issue shares to Heron in a private placement. The filing also furnished an investor call transcript regarding Q3 2026 financial results.
What does a acquisition mean for CRMD stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did CRMD stock react to this filing?
CRMD closed at $4.66 before the filing and $4.82 on Nov 16, 2026 (+3.43%).
Other CRMD SEC filings
- 10-Q · SEC filingNov 12, 2026
- 8-K · SEC filingNov 12, 2026
- 8-K · AcquisitionNov 10, 2026
- 8-K · AcquisitionNov 9, 2026
- 8-K · SEC filingNov 2, 2026
- 8-K · Fda approvalOct 19, 2026
- 8-K · SEC filingAug 13, 2026
- 10-Q · Material agreementAug 13, 2026
- 8-K · Legal settlementAug 7, 2026
- 8-K · Executive departureJul 2, 2026
Get alerts when CRMD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days